CIPLA MEDPRO MANUFACTURING:  
A world class contract manufacturing solution in South Africa

Already one of SA’s largest manufacturing plants, the SA Medicines Control Council (MCC) approved Cipla Medpro Manufacturing (CMM) has recently undergone a a R225 million upgrade to international PIC/S compliance.

Through its close association with Cipla India, experts in pharmaceutical manufacturing to globally accredited standards, the group has been fortunate to access their advice when ensuring the facility is best equipped for optimum compliance, capacities, flexibility and flow.

Being one of the first local manufacturers to attain PIC/S accreditation enables the group to manufacture some of its own products, as well as offer local and multinational pharmaceutical companies world class, high volume manufacturing solutions in line with MCC cGMP (current Good Manufacturing Practice) and PIC/S regulations. CMM is also one of only two facilities in South Africa offering effervescent manufacturing.

Features:

The state of the art facility features:

• 4 times greater capacity
• Annual planned capacity of 3,25 billion tablets with reserve capacity
• Environmentally controlled stores
• New laboratory dedicated to full analysis of raw materials, finished product and packaging materials
• Individual Air Handling Units per processing module, controlling temperature, humidity and airflow
• New processes for tablet and effervescent manufacturing
• Full validation and qualification of plant, equipment and processes

Capabilities:

• Tablets
• Capsules
• Powders
• Creams / Ointments
• Effervescent powders and granules
• Laboratory testing
• Full contract packing       

Processes:

• Wet granulation (vertical granulators, planetary mixers, FBE’s)
• Oven-drying
• Fluid-bed drying
• Aqueous and solvent based coating
• Effervescent manufacturing and packing

Packing:

• Foil on Foil Strip Packing
• Blister (PVC/ PVDC; Alu/Alu)
• Sachets
• Bulk packing
• Securitainers / bottles